| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.039 | 0.4 |